【摘要】 肝炎后肝硬变门静脉高压症肝炎病毒感染状况分析尚未引起外科医生应有的重视。本组资料显示 HBsAg、HBeAg、HBcAbb·IgM、及 HBcAb 与 HBsAg 同时阳性的比率分别高达70.9%、22.1%、37.6%及60.5%,说明2/3以上的肝炎后肝硬变门静脉高压症患者存在着乙型炎病毒(HBV)的现行感染,1/3以上为慢性乙型肝炎急性发作期或处于乙型肝炎急性期。在门静脉高压症阶段仍应重视抗病毒治疗。外科手术组与内科治疗组的 HBV 及丙型肝炎病毒(HCV)血清标志物分析均无显著性差异(P>0.05),说明有手术适应证的门静脉高压症患者 HRV-VCV 感染状况仍未得到控制。更多还原

【Abstract】 Active hepatitis virus mtection m posthepatitis liver cirrhosis with portal hypertension has not been brought to enough attention of surgeons.The present research demonstrated that the positice ratio of HBsAg,HBeAg, HBcAb·IgM,HBcAb and HBsAg were 70.9%, 22.1%,37.6% and 60.5%,respectively.More than 2/3 of patients with posthepatitis liver cirrhosis and portal hypertension have active infection of hepatitis B virus (HBV),in more than 1/3 of the patients exists active attack stage of chronic viral hepatitis B or active stage of chronic viral hepatitis B.During portal hypertensive peri- od,anti-virus therapy should still be undertaken.更多还原